Chronic Neuropathic Pain Epidemiology Forecast to 2030 by DelveInsight

Chronic Neuropathic Pain Epidemiology

Chronic Neuropathic Pain Epidemiology

Chronic Neuropathic Pain Epidemiology” report has been added to DelveInsight

Chronic Neuropathic Pain Overview

Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the general population.

Chronic Neuropathic Pain Epidemiology Forecast

DelveInsight’s ‘ Chronic Neuropathic Pain – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Chronic Neuropathic Pain epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Request free sample copy- https://www.delveinsight.com/sample-request/chronic-neuropathic-pain-epidemiology-forecast

Chronic Neuropathic Pain Epidemiology: Regions Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Chronic Neuropathic Pain Treatment

The treatment initially focuses on resolving the underlying cause. Medications used to treat neuropathic pain include over-the-counter analgesics, anticonvulsants, tricyclic antidepressants (TCAs), topical anesthetic agents, nonsteroidal anti-inflammatory drugs (NSAIDs), antiarrhythmics, narcotic analgesics, and opioids.

Chronic Neuropathic Pain Epidemiology Insights

Neuropathic pain is characterized by a “pain arising as a direct consequence of a lesion or disease of the somatosensory system”. The existing literature has primarily investigated the epidemiology of neuropathic pain within the context of specific diseases, such as cancer, diabetic peripheral neuropathy (DPN), and chronic low-back pain (CLBP). The study by Bouhassira et al. (2019), have shown that the prevalence of neuropathic pain in the general population may be as high as 7–8%, accounting for 20–25% of individuals with chronic pain.

Key facts of Chronic Neuropathic Pain Epidemiology report

  • “Neuropathic pain,” chronic neuropathic pain is more frequent in women (8% vs. 5.7% in men) and in patients >50 years of age (8.9% vs. 5.6% in those <49 years of age), and most commonly affects the lower back and lower limbs, neck and upper limbs. A survey of >12,000 patients with chronic pain with both nociceptive and neuropathic pain types, referred to pain specialists in Germany, revealed that 40% of all patients experience at least some characteristics of neuropathic pain.
  • “Epidemiology of neuropathic pain,” a study of German population has shown that in general 6.5% of respondents have reported pain with chronic neuropathic pain characteristics, and have reported higher intensity and more interference of pain in their daily activities as compared to individuals with chronic non-neuropathic pain.
  • According to an article by Melillo (2020), published on the American Journal of Managed Care, in France the prevalence of chronic neuropathic pain is around 6.9%. It is known that chronic neuropathic pain is more prevalent among females of older ages.

Chronic Neuropathic Pain Epidemiology Segmentation

  • Total Prevalent Cases
  • Age-specific Prevalent Cases
  • Gender-specific Prevalent Cases
  • Diagnosed and Treatable Cases

Chronic Neuropathic Pain Epidemiology Perspective

The Chronic Neuropathic Pain epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Chronic Neuropathic Pain epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Chronic Neuropathic Pain epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Chronic Neuropathic Pain Epidemiology Report Highlights

  • 11-Year Forecast of Chronic Neuropathic Pain epidemiology
  • 7MM Coverage
  • Total Cases of Chronic Neuropathic Pain
  • Total Cases of Chronic Neuropathic Pain according to segmentation
  • Diagnosed cases of Chronic Neuropathic Pain

Request free sample copy- https://www.delveinsight.com/sample-request/chronic-neuropathic-pain-epidemiology-forecast

Table of content

  1. Key Insights
  2. Executive Summary of Chronic Neuropathic Pain
  3. Chronic Neuropathic Pain: Disease Background and Overview
  4. Patient Journey
  5. Epidemiology and Patient Population
  6. Treatment Algorithm, Current Treatment, and Medical Practices
  7. KOL Views
  8. Unmet Needs
  9. Appendix
  10. DelveInsight Capabilities
  11. Disclaimer
  12. About DelveInsight

Chronic Neuropathic Pain Epidemiology Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Why should you buy this report?

  • Develop business strategies by understanding the trends shaping and driving the global Chronic Neuropathic Pain market
  • Quantify patient populations in the global Chronic Neuropathic Pain market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Chronic Neuropathic Pain therapeutics in each of the markets covered
  • Understand the magnitude of Chronic Neuropathic Pain population by its epidemiology
  • The Chronic Neuropathic Pain Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Related Reports

View Latest Reports

ADHD Market

DelveInsight’s Attention-deficit/hyperactivity disorder (ADHD) Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Farber’s Disease Market

DelveInsight’s Farber’s Disease Market Insights, Epidemiology and Market Forecast – 2030 report provides an in depth understanding of historical.

Transverse Myelitis Market

DelveInsight’s Transverse Myelitis Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Opioid-related Disorders Market

DelveInsight’s “Opioid-related Disorders Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding historical and forecasted epidemiology

Systemic Inflammatory Response Syndrome Market

DelveInsight’s “Opioid-related Disorders Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding market data

Paranasal Sinus Cancer Market

Paranasal Sinus Cancer market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted from 2017 to 2030 segmented by 7MM.

Cone Rod Dystrophy Market

DelveInsight’s Cone Rod Dystrophy – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Smallpox Market

DelveInsight’s Smallpox – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Shingles Market

DelveInsight’s Shingles- Market Insights, Epidemiology and Market Forecast – 2030 report provides an in depth understanding of historical.

Schistosomiasis Market

DelveInsight’s Schistosomiasis Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

Parainfluenza Virus Infection Market

DelveInsight’s Parainfluenza Virus Infection – Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed understanding of historical and forecasted epidemiology.

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us 

Shruti Thakur

[email protected]

+91-9650213330

https://goodnewsgum.com/

Leave a Reply

Your email address will not be published. Required fields are marked *